March 2026 in “Anais Brasileiros de Dermatologia” Facial aesthetic procedures improve quality of life for transgender individuals.
February 2026 in “PubMed” This study found that among women with female pattern hair loss, low-dose oral minoxidil improved hair loss severity and quality of life scores despite 71.6% experiencing mild to moderate unwanted hair growth, which most patients did not consider a reason to discontinue treatment.
January 2026 in “Dermatology Practical & Conceptual” This study reported that diffuse lichen planopilaris significantly impairs quality of life in Moroccan patients, with trichodynia and hair quality changes most affecting daily functioning and leisure activities.
January 2026 in “Figshare” In this study, women with female pattern hair loss using low-dose oral minoxidil reported significant improvements in hair loss severity and quality of life, with most experiencing mild or moderate unwanted hair growth but continuing treatment regardless.
January 2026 in “Figshare” This study found that women with female pattern hair loss experienced improvements in hair loss severity and quality of life from low-dose oral minoxidil use, despite a common side effect of unwanted hair growth, which most did not consider a reason to stop treatment.
January 2026 in “Egyptian Journal of Dermatology and Venerology” This study in Egyptian children found that scalp hair loss significantly impacts quality of life, with nearly half experiencing severe emotional and social challenges, particularly those with alopecia areata and tinea capitis.
January 2026 in “European Journal of Cancer Care” In this cross-sectional study, social support was found to improve empowerment and alopecia-related quality of life in breast cancer patients, with an indirect benefit on quality of life achieved through enhanced empowerment.
January 2026 in “Majmaah Journal of Health Sciences” This study found that female pattern hair loss in Saudi Arabian women significantly impacts their quality of life and social engagement, affecting self-image and societal acceptance, despite no notable psychological symptom correlation with hair loss severity.
This study found that treating androgenetic alopecia through a virtual healthcare platform significantly improved hair-loss-related quality of life over six months, with adherence to the program being a key factor in achieving better outcomes among the participants in Brazil.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, both alopecia areata and androgenetic alopecia were found to moderately impact quality of life, affecting emotional and social aspects in patients.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that both alopecia areata and androgenetic alopecia moderately impacted patients' quality of life, affecting not only physiological but also emotional and social aspects.
October 2025 in “Plastic & Reconstructive Surgery” This study evaluated the safety and effectiveness of MNC-QQ cell therapy in five men with androgenic alopecia, reporting no adverse effects and improvements in hair growth, hair density, and quality of life over six months.
October 2025 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” Hair loss negatively impacts quality of life, and psychological support can help.
August 2025 in “Annals of Indian Psychiatry” In a cross-sectional study, 46% of patients with androgenetic alopecia were found to have depression of borderline to moderate severity, while 62% reported no impact on their quality of life, emphasizing the need for awareness of psychiatric comorbidities among dermatologists.
July 2025 in “Agroindustrial Technology Journal” In this study, researchers evaluated shampoo formulations with varying concentrations of rosemary essential oil, finding that the 2% formulation was most preferred based on sensory tests, and complied well with quality standards, indicating its potential as an effective component in hair care products.
May 2025 in “Journal of Dispersion Science and Technology” This study reported that a novel SMEDDS formulation of PPO demonstrated better permeation and improved hair growth compared to a marketed formulation in tests for managing androgenetic alopecia, with further exploration suggested.
January 2025 in “Journal of Dermatology & Dermatologic Surgery” This study found that patients with telogen effluvium had a higher quality of life score compared to controls, despite no significant difference in self-esteem.
January 2025 in “Therapeutic Advances in Medical Oncology” This study found that many young women with breast cancer experience a poor quality of life over time, especially regarding sexual health, future perspective, and hair loss.
January 2025 in “ARC Journal of Dermatology” In this study, researchers observed significant racial disparities in alopecia quality of life research, with fewer studies and less funding focusing on Black patients compared to other racial groups, indicating a need for more inclusive and diverse participant recruitment.
November 2024 in “Psychology Health & Medicine” This study identified subgroups of people with alopecia areata with varying levels of quality of life impairment, influenced by feelings of flaw, coping styles, and social factors.
November 2024 in “IP Indian Journal of Clinical and Experimental Dermatology” In this study, researchers reported that alopecia areata significantly impacts quality of life, with effects ranging from small to very large, especially for those with longer disease duration, highlighting the importance of psychological evaluation and support for affected patients.
October 2024 in “INNOVATION RESEARCH JOURNAL” This study found a significant relationship between the severity of acne vulgaris and the quality of life among adolescents in Gresik, with many experiencing severe disturbances in quality of life related to more severe acne.
September 2024 in “International Journal For Multidisciplinary Research” In this observational study conducted in a dermatology outpatient setting, the researchers reported that minoxidil 5% was the most commonly prescribed treatment for androgenic alopecia, with male patients experiencing a greater impact on quality of life compared to females.
September 2024 in “Journal of the American Academy of Dermatology” In this study, Muslim women with alopecia who wear hijab generally reported a lesser impact on quality of life than those who do not wear hijab, and were less likely to seek medical care for their condition.
July 2024 in “Skin Appendage Disorders” This study reviews literature showing that trichotillomania significantly reduces quality of life and emphasizes that effective treatment requires an interdisciplinary approach involving dermatology and psychiatry to address its psychiatric component.
June 2024 in “Research Square (Research Square)” This study observed that combining botulinum toxin type A with Minoxidil significantly promoted hair growth, improved quality of life, and enhanced patient satisfaction in male androgenetic alopecia patients at 4 and 6 months, with no adverse effects compared to using Minoxidil alone.
May 2024 in “British Journal of Community Nursing” In this case series, researchers reviewed 38 case studies involving Prontosan® products for chronic lower limb ulcers and found that the treatments significantly improved wound healing and various quality of life outcomes, such as reduced malodour and pain, better mobility, and enhanced social life.
May 2024 in “International journal of medicine and psychology.” This study found that patients with chronic-stage true eczema and comorbid depression experienced a more severe disease progression, marked by higher inflammation levels and significantly reduced quality of life compared to those without depression.
April 2024 in “International journal of community medicine and public health/International journall of community medicine and public health” In this study, researchers found that female pattern hair loss significantly reduces quality of life, particularly affecting younger women who experience more stigmatization, poorer emotional stability, and higher dermatology life quality index scores compared to older women.
April 2024 in “Assiut Scientific Nursing Journal” In this study, researchers assessed the quality of life in 70 patients with alopecia areata, finding that treatment choice and age positively correlated with quality of life, while factors like sex, education, and knowledge did not.